SCHEMBL4487922

SCHEMBL4487922

CN(c1ccc(NC2CCCCC2)cc1)C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.44
MAPT P10636 3/20 0.44
POLB P06746 3/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
APAF1 O14727 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8702788 0.84 EPHX1 (0.59) EPHX1MAPTPOLBLMNAGAA
SCHEMBL10610448 0.84 EPHX1 (0.47) EPHX1MAPTPOLBLMNAGAA
SCHEMBL4485887 0.83 HRH4 (0.44) GAAKDM4EMEN1ALDH1A1KMT2A
SCHEMBL4479148 0.82 MAPT (0.46) EPHX1MAPTPOLBLMNAGAA
SCHEMBL4476002 0.80 MAPT (0.47) EPHX1MAPTPOLBLMNAGAA
SCHEMBL78145 0.79 MAPT (0.61) EPHX1MAPTPOLBLMNAGAA
SCHEMBL3400048 0.79 MAPT (0.61) EPHX1MAPTPOLBLMNAGAA
SCHEMBL11526941 0.79 MAPT (0.61) EPHX1MAPTPOLBLMNAGAA
SCHEMBL4483045 0.79 LMNA (0.41) EPHX1MAPTPOLBLMNAGAA
SCHEMBL4483736 0.79 POLB (0.41) EPHX1MAPTPOLBLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484983-B1 SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING MIXTURE OF ANTIOXIDANTS CHEVRON ORONITE CO (US) 2020-05-27 EP disclosed
EP-3484983-A1 SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING MIXTURE OF ANTIOXIDANTS Chevron Oronite Company LLC (US) 2019-05-22 EP disclosed
US-10077410-B2 Synergistic lubricating oil composition containing mixture of antioxidants CHEVRON ORONITE COMPANY LLC (US) 2018-09-18 US disclosed
US-20180016512-A1 Synergistic Lubricating Oil Composition Containing Mixture of Antioxidants CHEVRON ORONITE COMPANY LLC 2018-01-18 US disclosed
WO-2018013181-A1 SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING MIXTURE OF ANTIOXIDANTS CHEVRON ORONITE COMPANY LLC (US) 2018-01-18 WO disclosed
US-20090156441-A1 Cycloalkyl phenylenediamines as deposit control agents for lubricants GREAT LAKES CHEMICAL GLOBAL, INC. 2009-06-18 US disclosed
EP-0008307-A1 Polyurethane foams prepared from condensation products of amines, epihalohydrins and alkylene oxides BASF WYANDOTTE CORPORATION (US) 1980-03-05 EP disclosed
US-4133780-A Polyurethane foams prepared from condensation products of amines, epihalohydrins and alkylene oxides BASF WYANDOTTE CORPORATION (US) 1979-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156441-A1 Cycloalkyl phenylenediamines as deposit control agents for lubricants C5, C9, C1S EPHX1 1205/4885MAPT 2214/4885POLB 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.